goals of this talk
play

Goals of this talk HospitalBased Dermatology: Common and Tough - PDF document

11/7/2017 Goals of this talk HospitalBased Dermatology: Common and Tough Consult Cases Present common morphologies that arise during inpatient consultations Lindy P. Fox MD Associate Professor of Clinical Dermatology Director,


  1. 11/7/2017 Goals of this talk Hospital‐Based Dermatology: Common and Tough Consult Cases • Present common morphologies that arise during inpatient consultations Lindy P. Fox MD Associate Professor of Clinical Dermatology Director, Hospital Consultation Service • Generate a working differential diagnosis University of California, San Francisco lindy.fox@ucsf.edu • Use cases to demonstrate key teaching points about diagnosis or management I have no relevant conflicts of interest to disclose. I may discuss off‐label uses of medications . Common Morphologies in the Hospital Morbilliform • Measles‐ like 1. Morbilliform • Pink to red macules and papules 2. Cellulitic plaques – No surface change 3. Purpura • May be called “maculopapular” 4. Ulcers • Most common differential in the hospital: 5. Vesiculobullous – Drug eruption – Viral exanthem 6. Pustules – Acute Graft vs. Host Disease • Most often doesn’t need a biopsy 1

  2. 11/7/2017 Drug Eruptions: Drug Induced Hypersensitivity Syndrome Degrees of Severity • Skin eruption associated with systemic symptoms and alteration of internal organ function Simple Complex • “ DRESS ” ‐ Drug reaction w/ eosinophilia and systemic symptoms Morbilliform drug eruption Drug hypersensitivity reaction Stevens-Johnson syndrome • “ DIHS ” = Drug induced hypersensitivity syndrome (SJS) • Begins 2‐ 6 weeks after medication started Toxic epidermal necrolysis – time to abnormally metabolize the medication (TEN) • Role for viral reactivation, esp HHV6, CMV, EBV Minimal systemic symptoms – Can check these PCRs Systemic involvement • Mortality 10% Potentially life threatening DIHS‐ Clinical Features DIHS‐ Drugs • Rash • Aromatic anticonvulsants – FACIAL EDEMA • Fever (precedes eruption by day or more) – phenobarbital, carbamazepine, phenytoin • Pharyngitis – THESE CROSS‐REACT • Hepatitis • Sulfonamides • Arthralgias • Lamotrigine • Lymphadenopathy • Dapsone • Hematologic abnormalities • Allopurinol (HLA‐B*5801) – eosinophilia – atypical lymphocytosis • NSAIDs • Other organs involved • Other – Interstitial pneumonitis, interstitial nephritis, thyroiditis – Abacavir (HLA‐ B*5701) – Myocarditis‐ acute eosinophilic mycocarditis or acute necrotizing – Nevirapine (HLA‐DRB1*0101) eosinophilic myocarditis • EKG, echocardiogram, cardiac enzymes – Minocycline, metronidazole, azathioprine, gold salts 2

  3. 11/7/2017 Drug Induced Hypersensitivity Syndrome DIHS‐ Treatment • Stop the medication • Each class of drug causes a slightly different clinical picture • Follow CBC with diff, LFT ’ s, BUN/Cr • Facial edema characteristic of all • Avoid cross reacting medications!!!! • Anticonvulsants: – Aromatic anticonvulsants cross react (70%) – 3 weeks • Phenobarbital, Phenytoin, Carbamazepine – Atypical lymphocytosis, hepatic failure • Valproic acid and levetiracetam (Keppra) generally safe • Dapsone: • Systemic steroids (Prednisone 1.5‐2mg/kg) – 6 weeks – Taper slowly‐ 1‐3 months – No eosinophilia • For allopurinol start steroid sparing agent • Allopurinol: (mycophenolate mofetil) – 7 weeks • Completely recover, IF the hepatitis resolves – Elderly patient on thiazide diuretic • Check TSH monthly for 6 months – Renal failure • Watch for late cardiac involvement – Requires steroid sparing agent to treat (avoid azathioprine) – Counsel patient Cellulitic Plaques Cellulitis • Infection of the dermis • Red, edematous plaques • Gp A beta hemolytic • Often warm, tender strep and Staph aureus • If itchy, think contact dermatitis • Rapidly spreading • Most common differential in the hospital: • Erythematous, tender – Cellulitis plaque, not fluctuant – Stasis dermatitis • Patient often toxic – Contact dermatitis • WBC, LAD, streaking • Don’t miss – Pyomyositis • Rarely bilateral • Rarely needs a biopsy • Treat tinea pedis • Bacterial culture any open or draining area • If bilateral, think stasis dermatitis, contact dermatitis 3

  4. 11/7/2017 Stasis Dermatitis Called to evaluate cellulitis not responding to vancomycin • Often bilateral, L>R • Itchy and/or painful • Red, hot, swollen leg Exquisite pain +/‐Persistent • No fever, elevated WBC, fever LAD, streaking Not responding • Look for: varicosities, to antibiotics edema, venous ulceration, No LAD hemosiderin deposition • Superimposed contact dermatitis common Question: Question: Your Next Step Is: Your Next Step Is: 1. ID consult 1. ID consult 2. MRI 2. MRI 3. Ultrasound 3. Ultrasound 4. Surgery consult 4. Surgery consult 5. Add gram negative coverage 5. Add gram negative coverage 4

  5. 11/7/2017 Pyomyositis • Acute primary bacterial infection of skeletal muscle  “ Bag of pus ” • Trauma, travel, immunosuppression, diabetes • Etiologic Agents – Staphylococcus aureus (77%) – Streptococcus species (12%) • Group A streptococcus • Not helpful: fever, CK, labs, blood cultures • Image: MRI > CT > US • Treatment: surgical drainage + antibiotics Palpable purpura • Nonblanching red to purple papules • Most common differential in the hospital: – Small or mixed (small and medium) vessel vasculitis – Secondary hemorrhage into papular process • Always needs a biopsy for H+E, direct immunofluorescence, culture • Consult dermatology if possible 5

  6. 11/7/2017 Consult: 23F, 2 weeks of palpable purpura, calf pain, arthralgias, and abdominal pain Vasculitis • Clinical morphology correlates with the size of the affected vessel – Small vessel disease (post capillary venules) • Urticaria and palpable purpura – Small‐artery disease • Subcutaneous nodules – Medium‐vessel disease • Organ damage, livedo, purpura, mononeuritis multiplex – Large‐vessel disease • Claudication and necrosis 6

  7. 11/7/2017 Palpable Purpura‐ Leukocytoclastic Vasculitis Palpable Purpura • Conditions associated with LCV • Immune complex vasculitis • Pauci‐immune complex – Idiopathic (45‐55%) – Idiopathic, infection, drug, vasculitis – Infection (15‐20%) malignancy – ANCA‐ associated – IgA vasculitis, Henoch‐Schönlein • Microscopic polyangiitis – Inflammatory diseases (15‐20%) purpura • Granulomatosis with – Urticarial vasculitis polyangiitis – Medications (10‐15%) • Eosinophilic granulomatosis – Hypergammaglobulinemic – Malignancy (<5%) with polyangiitis purpura of Waldenström – Levamisole – Bowel‐bypass syndrome – Sweet ’ s syndrome – Mixed cryoglobulinemia – Connective tissue disease associated Palpable Purpura “ PLUS ” Small Vessel Vasculitis‐ Evaluation • • H+P, including medications – Blood culture Size of vessels is a clinical clue to underlying etiology – CBC with differential and ROS • Medium‐sized vessel involvement leads to • Skin biopsy for H+E, direct – Urinalysis with micro dermal/subcutaneous nodules, ulcerations, livedo, – Creatinine immunofluorescence, and/or retiform purpura – Stool guaiac culture • Differential diagnosis – Rheumatoid factor • – ASO, throat culture IgA vasculitis – Hepatitis B, C serologies • Septic vasculitis – ANA • ANCA‐associated vasculitis – Complement • Levamisole – ANCA • Mixed cryoglobulinemia – Cryoglobulins • Connective tissue disease associated – Immunofixation electrophoresis • Leukemic vasculitis – PPD or quantiferon gold • Polyarteritis nodosa (very rare) – Toxicology screen (levamisole) • More than one process occurring simultaneously – Age appropriate malignancy screen 7

  8. 11/7/2017 Ulcers Case • 67M ‐elective saphenous vein phlebectomy • Breakdown of skin to reveal dermis • 4d post op ‐erythema around wound • Multiple debridements and broad spectrum • Most common differential in the hospital: antibiotics – Venous insufficiency ulcers • Ulcer continues to expand – Pyoderma gangrenosum – Viral infections (HSV, CMV) • Wound cultures are negative • Tmax 104, WBC 22 • Culture for bacteria and virus when suspect • Transferred to UCSF 3 weeks later infection • Biopsy may be helpful – Send for H+E and culture Pyoderma Gangrenosum Pyoderma Gangrenosum • Rapidly progressive (days) ulcerative process • 50% have no underlying cause • Begins as small pustule which breaks down forming • Associations (50%): an ulcer • Undermined violaceous border – Inflammatory bowel disease (1.5%‐5% of IBD • Expands by small peripheral satellite ulcerations patients get PG) which merge with the central larger ulcer – Rheumatoid arthritis • Occur anywhere on body – Seronegative arthritis • Triggered by trauma (pathergy) – Hematologic – surgical debridement, attempts to graft abnormalities (AML) 8

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend